VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (4494)	3/30/1998 12:07:00 AM
From: Rocketman	Read Replies (3) of 9719

Beat ya both out, I bailed CYTO around $4.50 when I paid taxes last October. I can't believe how low they've sunk though. I like GZTC also and transgenics in general, but they still have a ways to go until these companies will be profitable IMHO. My guess is that even when they get a revenue stream from actual products that they will be pumping all the revenue and more equity and deal capital back into the business to keep growing it for quite some time to come. Over the long haul this is the best strategy, but for the quarter to quarter trader mentality, they won't like it one bit. I do expect that the time frames and costs to develop the transgenic animals will drop drastically through time though.....kind of like Moore's law. The efficiencies of the processes will continue to make quantum improvements. However, the FDA will always be a slow Dinosaur IMO, after all they are just a huge government bureaucracy. One of the big pluses about GZTC is the contract research part of it that isn't dependent on getting a drug approved and marketed. Rman

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next